
@Article{biocell.2022.018409,
AUTHOR = {MICHELE DI COSOLA; STEFANIA CANTORE; MARIO GIOSUÈ BALZANELLI; CIRO GARGIULO ISACCO; KIEU CAO DIEM NGUYEN; RAJIV SAINI; ANNARITA MALCANGI; MARGHERITA TUMEDEI; MARIATERESA AMBROSINO; ANTONIO MANCINI; SALVATORE SCACCO; RICCARDO NOCINI; LUIGI SANTACROCE; ANDREA BALLINI; EDOARDO BRAUNER},
TITLE = {Dental-derived stem cells and biowaste biomaterials: What’s next in bone regenerative medicine applications},
JOURNAL = {BIOCELL},
VOLUME = {46},
YEAR = {2022},
NUMBER = {4},
PAGES = {923--929},
URL = {http://www.techscience.com/biocell/v46n4/45995},
ISSN = {1667-5746},
ABSTRACT = {The human teeth and oral cavity harbor various populations of mesenchymal stem cells (MSCs), so called
dental-derived stem cells (D-dSCs) with self-renewing and multilineage differentiation capabilities. D-dSCs properties
involves a strong paracrine component resulting from the high levels of bioactive molecules they secrete in response
to the local microenvironment. Altogether, this viewpoint develops a general picture of current innovative strategies
to employ D-dSCs combined with biomaterials and bioactive factors for regenerative medicine purposes, and offers
information regarding the available scientific data and possible applications.},
DOI = {10.32604/biocell.2022.018409}
}



